NYSE: AMPE - Ampio Pharmaceuticals, Inc.

Yield per half year: -72.73%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Ampio Pharmaceuticals, Inc.


About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.


IPO date 2010-03-31
ISIN US03209T1097
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://ampiopharma.com
Цена ао 0.0021
Change price per day: 0% (0.0006)
Change price per week: -71.43% (0.0021)
Change price per month: -71.43% (0.0021)
Change price per 3 month: +20% (0.0005)
Change price per half year: -72.73% (0.0022)
Change price per year: -99.93% (0.92)
Change price per 3 year: -99.86% (0.431)
Change price per 5 year: -99.9% (0.59)
Change price per year to date: -76.92% (0.0026)

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.4629 10
P/E 0 0
EV/EBITDA 0.2438 10
Total: 5

Efficiency

Title Value Grade
ROA, % -150.49 0
ROE, % -256.9 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0296 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 6099.8 10
Yield Ebitda, % -57.7 0
Yield EPS, % -41.84 0
Total: 2



Head Job title Payment Year of birth
Mr. Michael A. Martino CEO, CFO, General Secretary & Director 550k 1957 (68 years)
Dr. David Bar-Or M.D. Founder & Chairman of Scientific Advisory Board 145.6k 1949 (76 years)
April Ramirez Clinical Trial Manager N/A

Address: United States, Englewood. CO, 9800 Mount Pyramid Court - open in Google maps, open in Yandex maps
Website: https://ampiopharma.com